Deutsche Bank’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-15,823
| Closed | -$149K | – | 4624 |
|
|
2020
Q3 | $149K | Sell |
15,823
-413
| -3% | -$3.93K | ﹤0.01% | 3369 |
|
|
2020
Q2 | $125K | Buy |
16,236
+5,700
| +54% | +$43.6K | ﹤0.01% | 3346 |
|
|
2020
Q1 | $65K | Sell |
10,536
-678
| -6% | -$5.97K | ﹤0.01% | 3428 |
|
|
2019
Q4 | $136K | Buy |
11,214
+2,532
| +29% | +$27.7K | ﹤0.01% | 3436 |
|
|
2019
Q3 | $99K | Sell |
8,682
-185,837
| -96% | -$1.96M | ﹤0.01% | 3565 |
|
|
2019
Q2 | $1.94M | Sell |
194,519
-13,870
| -7% | -$150K | ﹤0.01% | 2411 |
|
|
2019
Q1 | $2.68M | Sell |
208,389
-50,685
| -20% | -$755K | ﹤0.01% | 2274 |
|
|
2018
Q4 | $3.93M | Buy |
259,074
+3,774
| +1% | +$71.9K | ﹤0.01% | 1949 |
|
|
2018
Q3 | $5.11M | Buy |
255,300
+4,801
| +2% | +$109K | ﹤0.01% | 2177 |
|
|
2018
Q2 | $4.88M | Sell |
250,499
-7,536
| -3% | -$167K | ﹤0.01% | 2314 |
|
|
2018
Q1 | $5.2M | Buy |
258,035
+148,875
| +136% | +$2.52M | ﹤0.01% | 2181 |
|
|
2017
Q4 | $1.44M | Sell |
109,160
-146
| -0.1% | -$2.2K | ﹤0.01% | 2952 |
|
|
2017
Q3 | $2.01M | Sell |
109,306
-27,040
| -20% | -$504K | ﹤0.01% | 2538 |
|
|
2017
Q2 | $2.51M | Sell |
136,346
-400,413
| -75% | -$7.93M | ﹤0.01% | 2404 |
|
|
2017
Q1 | $12.1M | Buy |
536,759
+141,681
| +36% | +$3.39M | 0.01% | 1143 |
|
|
2016
Q4 | $13.7M | Buy |
395,078
+16,881
| +4% | +$504K | 0.01% | 1069 |
|
|
2016
Q3 | $9.27M | Sell |
378,197
-81,911
| -18% | -$2.05M | 0.01% | 1359 |
|
|
2016
Q2 | $11M | Buy |
460,108
+188,197
| +69% | +$4.31M | 0.01% | 1248 |
|
|
2016
Q1 | $6.36M | Sell |
271,911
-173,067
| -39% | -$4.11M | ﹤0.01% | 1582 |
|
|
2015
Q4 | $13.4M | Buy |
444,978
+284,319
| +177% | +$9.19M | 0.01% | 1150 |
|
|
2015
Q3 | $6.38M | Buy |
160,659
+96,307
| +150% | +$5.98M | ﹤0.01% | 1618 |
|
|
2015
Q2 | $4.44M | Sell |
64,352
-46,619
| -42% | -$2.93M | ﹤0.01% | 1876 |
|
|
2015
Q1 | $6.06M | Buy |
110,971
+27,861
| +34% | +$1.33M | ﹤0.01% | 1663 |
|
|
2014
Q4 | $3.54M | Sell |
83,110
-8,037
| -9% | -$290K | ﹤0.01% | 2233 |
|
|
2014
Q3 | $2.91M | Sell |
91,147
-1,882
| -2% | -$40.1K | ﹤0.01% | 2240 |
|
|
2014
Q2 | $1.93M | Sell |
93,029
-10,128
| -10% | -$187K | ﹤0.01% | 2462 |
|
|
2014
Q1 | $2M | Buy |
103,157
+94,376
| +1,075% | +$2M | ﹤0.01% | 2401 |
|
|
2013
Q4 | $212K | Sell |
8,781
-36,287
| -81% | -$853K | ﹤0.01% | 3668 |
|
|
2013
Q3 | $965K | Buy |
45,068
+9,972
| +28% | +$236K | ﹤0.01% | 3000 |
|
|
2013
Q2 | $779K | Buy |
+35,096
| New | +$773K | ﹤0.01% | 2867 |
|
Deutsche Bank's AMAG Position: Q4 2020 in Review
Deutsche Bank sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 15,823 shares — an estimated $149K sold.
Deutsche Bank first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $13.7M in Q4 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Deutsche Bank reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Deutsche Bank sold 15,823 AMAG Pharmaceuticals shares in Q4 2020, an estimated $149K.
- Deutsche Bank first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Deutsche Bank's AMAG Pharmaceuticals position peaked at $13.7M in Q4 2016.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Deutsche Bank's 13F filing for Q4 2020, filed 16 Feb 2021.